Swee Yeok is the Chair and Founding Partner of AGP, and is the Senior Advisor to EDBI. She is an experienced business leader with over 35 years of expertise in management, investments, and strategy development. Prior to this she was the CEO and President of EDBI since 2009, responsible for the development and execution of investment strategies at EDBI. Championing the management of multi billion-dollar assets in funds and direct investments spanning US, Europe, China, SEA and Singapore in healthcare, digital technologies, financial services, advanced manufacturing, sustainability, and other high growth sectors, she successfully transformed EDBI from a passive state-owned fund management company into an active, reputable internationally recognized investor on a global stage. Prior to EDBI, she was the founding CEO of Bio*Capital, a billion-dollar global biomedical healthcare fund, which made significant investments in US, Europe and China, including seeding many innovative start ups and joint venture companies in Singapore. She was a pioneer of Singapore’s biomedical initiatives including establishing the first global biotech funds at EDB in 1980s. Additionally, whilst at EDB and A*STAR where she helmed concurrent senior positions, she drove the conceptualization of strategic plans and their successful execution through multiple agencies, laying the necessary foundations for growing the healthcare biomedical sector into one of the major contributors of Singapore’s economy today. Swee Yeok brings with her deep experience and extensive network into the local and overseas ecosystems of industries that she has been involved in over the last 35 years. She serves on the board of NHG, the largest healthcare group in Singapore as well as several other private and public companies. She also advises research entities like A*STAR on research translation and commercialization strategies. Ms Chu graduated with BSc Honors in Biochemistry from NUS and from Harvard Business School’s Executive Advanced Management Program.

Dr Basil Lui, Founding Partner of AGP, is a seasoned investor and healthcare technology expert. As former Managing Partner at EDBI, he led investments in groundbreaking healthcare ventures, including digital healthcare platforms, precision medicine companies, AI driven healthcare solution providers, and mRNA vaccine developers. His expertise spans regenerative technologies, connected health, and emerging fields like synthetic biology and AI in healthcare. Basil's investment acumen extends to early-stage deep-tech fund-of-funds, with a focus on regional healthcare funds. His background includes roles as a McKinsey consultant, APAC President of a semiconductor EDA company, and academic positions at NUS and Cambridge University. With a PhD from Cambridge and multiple patents to his name, Basil combines deep technical knowledge with strategic investment insights, driving innovation in healthcare and emerging technologies.

Davian is the MD, Investments of AGP. Prior to this he was the Senior Principal of Investments at EDBI where he was responsible for originating, leading and negotiating investments in areas such as Manufacturing/Advanced Manufacturing, Healthcare Services and Technology. Specifically, Davian successfully led several healthcare investment transactions in services and industrial manufacturing such as Dontia Alliance, a pan-Asian specialist focused dental services company; Meiban, an Asian based medtech manufacturer; and Esco Lifesciences, a global medical equipment and devices brand and manufacturer. He also represented EDBI as a board observer in several of its portfolio companies. Before EDBI, he was responsible for strategic investments and divestiture at Aalst-Wilmar, an associate company of Wilmar International focused on industrial chocolate and cocoa and prior to that, focused on growth and buyout transactions at BXR Group, an international private investment group specialised on large ticket investments in infrastructure, real estate and resources and; middle market investments in healthcare and education. Davian started his investment career at Credence Partners (now known as Altara Ventures), a Southeast Asian small/mid cap focused private equity fund focused on Consumer, Services, Logistics, Manufacturing and Technology. Davian’s overall deal experience ranges widely, from minority stake growth transactions and leveraged buyous, to M&As and joint ventures. Throughout his career, he was also seconded to various portfolio companies to assist with commercial negotiations, operations and strategic business development activities. Davian began his career at PrimePartners Corporate Finance, a boutique investment banking outfit advising clients on capital market transactions. He is a qualified CPA (Australia) and graduated with a Master of Applied Finance from Macquarie University, Sydney and a Bachelor of Commerce from The Australian National University, Canberra.

Warren is part of the AGP Investments team. He was previously at SGInnovate, where he covered corporate engagement and venture deals under the healthcare and agrifood verticals. Earlier, he was an innovation consultant with Alcimed, where he supported corporates in innovation sourcing and technology landscaping. Warren graduated from the National University of Singapore with a PhD and BSc (1st class) in Life Sciences. In his doctoral research, he developed quantitative LC-MS panels, and screened for heart disease biomarkers in clinical cohorts. He also holds a BSc (1st class) in Applied Accounting from Oxford Brookes University and is continuing to hone his skills in finance as a CFA program participant.

Gabriel is part of the AGP Investments team. Prior to this, he spent time with Capital Code where he worked on several transactions including capital raising, M&A, and financial due diligence in the Industrials and Food & Agriculture sectors. Before Capital Code, he was with Abacus Capital where he was involved in dozens of transactions in a wide range of industries spanning Hospitality, F&B, Agriculture, Energy, and the Services sector. Gabriel graduated from Singapore Management University with a Bachelor of Business Management (cum laude), with a major in Finance.

Chris Koh is a multifaceted professional with a strong background in entrepreneurship, marketing, operations, and trading. He holds a Bachelor of Commerce with double majors in Economics and Finance from Monash University, Melbourne. Chris has essential experience in an SME, where he played a key role in marketing, operations, and business development with various industry stakeholders. He has also previously worked as an independent trader, specializing in funding arbitrage, market analysis, and risk-reward decision-making across diverse financial markets.